Specifying Contract Research Organization Services for a Prospective Observational Follow-Up of an Authorized Autologous Gene-Edited Cell Therapy: A Request-for-Proposal Framework

When a gene therapy has already shown substantial benefit and has been authorized, the scientifically honest next study is rarely another efficacy trial. This article builds a request for proposal (RFP) for a contract research organization (CRO) to run a 24-month, multicenter, prospective, non-interventional cohort study of adults with sickle cell disease previously treated, within routine authorized care, with a hypothetical autologous CRISPR/Cas9-edited hematopoietic stem cell therapy that raises fetal hemoglobin. The study neither procures nor administers the product. The article develops the evidence-to-RFP logic, specifies a 40-participant planning cohort at four to six United States centers, work packages, a 42-month timeline, a budget envelope of USD 1,805,500, a risk register, and weighted selection criteria, and addresses the regulatory classification, privacy, and safety-reporting questions that an observational gene therapy study raises. It emphasizes that a 24-month cohort cannot replace the long-term follow-up that regulators expect for genome-edited products.Keywords: request for proposal; gene editing; sickle cell disease; observational study; long-term follow-up; CRO; ICH E6(R3); real-world data

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24425493
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Specifying Contract Research Organization Services for a Prospective Observational Follow-Up of an Authorized Autologous Gene-Edited Cell Therapy: A Request-for-Proposal Framework

Dorcas Koomson, Peivand Pirouzi, Gloria Anthonia Amoateng Agyemang
Zenodo (CERN European Organization for Nuclear Research)
Biomedical Ethics and Regulation
article

Specifying Contract Research Organization Services for a Prospective Observational Follow-Up of an Authorized Autologous Gene-Edited Cell Therapy: A Request-for-Proposal Framework

Dorcas Koomson, Peivand Pirouzi, Gloria Anthonia Amoateng Agyemang
article en

Abstract

When a gene therapy has already shown substantial benefit and has been authorized, the scientifically honest next study is rarely another efficacy trial. This article builds a request for proposal (RFP) for a contract research organization (CRO) to run a 24-month, multicenter, prospective, non-interventional cohort study of adults with sickle cell disease previously treated, within routine authorized care, with a hypothetical autologous CRISPR/Cas9-edited hematopoietic stem cell therapy that raises fetal hemoglobin. The study neither procures nor administers the product. The article develops the evidence-to-RFP logic, specifies a 40-participant planning cohort at four to six United States centers, work packages, a 42-month timeline, a budget envelope of USD 1,805,500, a risk register, and weighted selection criteria, and addresses the regulatory classification, privacy, and safety-reporting questions that an observational gene therapy study raises. It emphasizes that a 24-month cohort cannot replace the long-term follow-up that regulators expect for genome-edited products.Keywords: request for proposal; gene editing; sickle cell disease; observational study; long-term follow-up; CRO; ICH E6(R3); real-world data

Zenodo (CERN European Organization for Nuclear Research)
Northeastern University (US)
Biomedical Ethics and Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Specifying Contract Research Organization Services for a Prospective Observational Follow-Up of an Authorized Autologous Gene-Edited Cell Therapy: A Request-for-Proposal Framework — Dorcas Koomson, Peivand Pirouzi, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS